OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action</p>
Philippe Nuss, Florian Ferreri, Michel Bourin
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 1781-1795
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 206

The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 97

Intranasal dantrolene nanoparticles inhibit lipopolysaccharide-induced depression and anxiety behavior in mice
Huafeng Wei, Jia Liu, Yan Lü, et al.
Research Square (Research Square) (2025)
Open Access | Times Cited: 1

Presentation and management of anxiety in individuals with acute symptomatic or asymptomatic COVID-19 infection, and in the post-COVID-19 recovery phase
Genoveva Uzunova, Stefano Pallanti, Eric Hollander
International Journal of Psychiatry in Clinical Practice (2021) Vol. 25, Iss. 2, pp. 115-131
Closed Access | Times Cited: 44

The human microglial surveillant phenotype is preserved by de novo neurosteroidogenesis through the control of cholesterol homeostasis: Crucial role of 18 kDa Translocator Protein
Elisa Angeloni, Lorenzo Germelli, Laura Marchetti, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166751-166751
Closed Access | Times Cited: 8

Palladium-catalyzed synthesis of 4-sila-4H-benzo[d][1,3]oxazines by intramolecular Hiyama coupling
Donghyeon Lee, Ryo Shintani
Chemical Science (2023) Vol. 14, Iss. 15, pp. 4114-4119
Open Access | Times Cited: 7

Anxiolytic-like effects of citral in the mouse elevated plus maze: involvement of GABAergic and serotonergic transmissions
Akbar Hajizadeh Moghaddam, Mohammad Amin Mashayekhpour, Mohaddeseh Abouhosseini Tabari
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 2, pp. 301-309
Closed Access | Times Cited: 10

Etifoxine is non-inferior than clonazepam for reduction of anxiety symptoms in the treatment of anxiety disorders: a randomized, double blind, non-inferiority trial
Benjamín Vicente, Sandra Saldivia, Naín Hormazabal, et al.
Psychopharmacology (2020) Vol. 237, Iss. 11, pp. 3357-3367
Closed Access | Times Cited: 16

A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration
Petra Bloms–Funke, Michaël Schumacher, Song Liu, et al.
European Journal of Pharmacology (2022) Vol. 923, pp. 174935-174935
Closed Access | Times Cited: 7

TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice
Hui Zhang, Li Ma, Wenzhi Guo, et al.
Brain Research Bulletin (2020) Vol. 165, pp. 178-184
Closed Access | Times Cited: 10

Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine
Lisa‐Marie Bahr, Franziska Maurer, Johannes Weigl, et al.
Psychoneuroendocrinology (2020) Vol. 124, pp. 105100-105100
Closed Access | Times Cited: 9

TSPO: an emerging role in appetite for a therapeutically promising biomarker
Joshua Wang, Kate Beecher
Open Biology (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 9

Post-traumatic stress disorder – from traumatic neurosis to ICD-11: features of diagnosis and selection of therapy
A. V. Vasileva
Meditsinskiy sovet = Medical Council (2023), Iss. 3, pp. 94-108
Open Access | Times Cited: 3

A role of neurosteroids in the pathogenesis of psychiatric disorders
D. S. Petelin, Sakeena Bairamova, Р. В. Ахапкин, et al.
S S Korsakov Journal of Neurology and Psychiatry (2023) Vol. 123, Iss. 4, pp. 31-31
Closed Access | Times Cited: 2

Catalyst-Free Synthesis of Functionalized 4-Substituted-4H-Benzo[d][1,3]oxazines via Intramolecular Cyclization of ortho-Amide-N-tosylhydrazones
Jun Yan, Christine Tran, Pascal Retailleau, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 13, pp. 8636-8642
Closed Access | Times Cited: 2

Analysis of the Underlying Mechanism of the Jiu Wei Zhen Xin Formula for Treating Generalized Anxiety Disorder Based on Network Pharmacology of Traditional Chinese Medicine
Heng Shao, Quan Gan, Zhuangfei Chen, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 3

Allosteric modulators of the δ GABAA receptor subtype demonstrate a therapeutic effect in morphine-antinociceptive tolerance and withdrawal in mice
Karina Genaro, Ryan F. Yoshimura, B P Doan, et al.
Neuropharmacology (2022) Vol. 219, pp. 109221-109221
Open Access | Times Cited: 3

Method Development and Validation for Estimation of Etifoxine in Capsule Dosage Form by Using RP-HPLC/UV
Mannava Laharika Choudary, Medidi Srinivas, Bula Udaya Kumari
Journal of Drug Delivery and Therapeutics (2024) Vol. 14, Iss. 7, pp. 64-70
Open Access

Palladium-Catalyzed Reactions of 2-Silylaryl Triflates for the Synthesis of Cyclic Organosilanes
Ryo Shintani
Journal of Synthetic Organic Chemistry Japan (2024) Vol. 82, Iss. 8, pp. 791-801
Closed Access

The possibilities of using effective anti-anxiety therapy in the practice of a neurologist
P. V. Aronov, G. N. Belskaya, D. I. Cherepakhin
Meditsinskiy sovet = Medical Council (2024), Iss. 12, pp. 45-51
Open Access

Emerging medications in psychiatry: Transforming the treatment landscape for depression and psychosis in Parkinson’s disease
Brijesh Saran, Tripta S. Bhagat, Rohit Bhagat
Santosh University Journal of Health Sciences (2024) Vol. 10, Iss. 2, pp. 209-219
Closed Access

Comorbid anxiety disorders in patients with neurological pathology: current state of the problem and the role of etifoxine in treatment strategy
Н. Г. Незнанов, M. М. Tanashyan, Е. С. Акарачкова, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 12, pp. 126-126
Closed Access

Prescribed Psychotropic Drugs in the Elderly
Michel Bourin
Springer eBooks (2021), pp. 647-660
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top